Spero Therapeutics, Inc. (SPRO)
2.28
-0.03
(-1.30%)
USD |
NASDAQ |
Dec 09, 09:46
Spero Therapeutics EPS Diluted (Quarterly): -0.1312 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Omeros Corp. | -0.4666 |
| GeoVax Labs, Inc. | -0.3115 |
| Vistagen Therapeutics, Inc. | -0.5432 |
| Daré Bioscience, Inc. | -0.2793 |
| Hyperion DeFi, Inc. | 0.0544 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.382M |
| Revenue (Quarterly) | 3.048M |
| Total Expenses (Quarterly) | 10.43M |
| Enterprise Value | 84.88M |
| Profit Margin (Quarterly) | -242.2% |
| Earnings Yield | -34.86% |
| Normalized Earnings Yield | -33.91 |